No menu items!

This Drug Could End H.I.V. Why Hasn’t It?

Dr. Robert Grant developed a treatment — a daily pill known as pre-exposure prophylaxis, or PrEP — that could stop the AIDS crisis. We look at why that hasn’t happened. Guests: Dr. Grant, who has been working on H.I.V. treatment and prevention for over 30 years, and Donald G. McNeil Jr., a science and health reporter for The New York Times. For more information on today’s episode, visit nytimes.com/thedaily.

Background reading:

All-in-One
Alternative Bank Solution
Highly secured Crypto Trading Platform
Checkout IXFI Friendly Crypto Exchange

More from author

Related posts

AdvertismentIXFI Friendly Exchange

Latest posts

Ether staking is too difficult, community members claim

Some are arguing that it would be healthy to admit that Ether staking is not for everyone yet.

BTC price still not at ‘max pain’ — 5 things to know in Bitcoin this week

Bitcoin has plenty of obstacles to weather in the current macro storm as two-year weekly close lows remain inches away.

Sam Bankman-Fried sheds light on how FTX would approach a Celsius bid

The FTX founder said the company paid the “fair market price” for Voyager’s assets and would look to do the same in a deal...

Want to stay up to date with the latest news?

We would love to hear from you! Please fill in your details and we will stay in touch. It's that simple!